NDC-1308, a novel compound inducing remyelination and slowing clinical signs in EAE mice Oct. 10, 2013
First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis Oct. 9, 2013
Presentations describe preclinical data on hepatitis B treatment candidate bentysrepinine Oct. 8, 2013
RSS